Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.

@article{Dunford2008StructureactivityRA,
  title={Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.},
  author={James E. Dunford and Aaron A. Kwaasi and Michael J Rogers and B. Lewis Barnett and Frank H. Ebetino and R. Graham G. Russell and Udo C. T. Oppermann and Kathryn L. Kavanagh},
  journal={Journal of medicinal chemistry},
  year={2008},
  volume={51 7},
  pages={2187-95}
}
The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final K(i)s and calculating the isomerization constant K(isom) for many N-BPs… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

Structural genomics-impact on biomedicine and drug discovery.

Experimental cell research • 2010
View 7 Excerpts
Highly Influenced

The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1‐Fluoro‐2‐(Imidazo‐[1,2‐α]Pyridin‐3‐yl)‐Ethyl‐Bisphosphonate)

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • 2017
View 1 Excerpt

zoledronic acid . 2 3

Marco Mozzati DDSa, Germana Martinasso PhDb, +6 authors Rosa Angela Canuto
2016

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • 2007

Human farnesyl diphosphate synthase crystal structures with active and inactive bisphosphonates

A. Evdokimov, M. Pokross, +5 authors F. H. Ebetino
Bone 2006, • 2006

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.

Proceedings of the National Academy of Sciences of the United States of America • 2006

Bisphosphonates in breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology • 2005

Similar Papers

Loading similar papers…